搜索结果
ID | 拉丁名 | 药名 | 药用植物名 | 功能与主治 | 来源 | 药用部位 | 使用民族 |
---|
化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
---|
TCMBANKIN058861 | ginsenoside rd;20-glucosylginsenosiderf;20-glucosylginsenosiderf | ginsenoside-rd; ginsenosiderd; A829210; 2-(hydroxymethyl)-6-[6-(hydroxymethyl)-2-[[17-[2-[6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-6-methyl-hept-5-en-2-yl]-4,4,8,10,14-pentamethyl-3,12-bis(oxidanyl)-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-b; 2-[[2-[[3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[6-methyl-2-[[3,4,5-trihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]hept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)-3-oxanyl]oxy]-6;(2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-2-[[(6S,14R)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[(2S)-6-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol; 20-glucosylginsenoside rf; AC1O3DDF;;20-glucosylginsenosiderf;20-glucosylginsenosiderf | C48H82O18 | 947.15 | CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CC(C4C3(CCC(C4(C)C)O)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)O)C)OC7C(C(C(C(O7)CO)O)O)O)C |
靶点ID | 基因名 | 基因别名 | 描述 |
---|
TCMBANKGE002979 | MYL9 | LC20; MLC-2C; MLC2; MRLC1; MYRL2 | myosin light chain 9 |
TCMBANKGE004030 | AVPR1A | AVPR V1a; AVPR1; V1aR | arginine vasopressin receptor 1A |
TCMBANKGE000881 | PLAT | T-PA; TPA | plasminogen activator, tissue type |
TCMBANKGE000545 | CXCL2 | CINC-2a; GRO2; GROb; MGSA-b; MIP-2a; MIP2; MIP2A; SCYB2 | C-X-C motif chemokine ligand 2 |
TCMBANKGE000562 | IL18 | IGIF; IL-18; IL-1g; IL1F4 | interleukin 18 |
TCMBANKGE000137 | PLAU | ATF; BDPLT5; QPD; UPA; URK; u-PA | plasminogen activator, urokinase |
TCMBANKGE003153 | DMD | BMD; CMD3B; DXS142; DXS164; DXS206; DXS230; DXS239; DXS268; DXS269; DXS270; DXS272; MRX85 | dystrophin |
TCMBANKGE007721 | C5 | C5D; C5a; C5b; CPAMD4; ECLZB | complement C5 |
TCMBANKGE000205 | NOS2 | HEP-NOS; INOS; NOS; NOS2A | nitric oxide synthase 2 |
TCMBANKGE004064 | SLC7A11 | CCBR1; xCT | solute carrier family 7 member 11 |
TCMBANKGE000663 | AQP4 | MIWC; WCH4 | aquaporin 4 |
TCMBANKGE009604 | NPPB | BNP | natriuretic peptide B |
TCMBANKGE011947 | AQP1 | AQP-CHIP; CHIP28; CO | aquaporin 1 (Colton blood group) |
TCMBANKGE000199 | ICAM1 | BB2; CD54; P3.58 | intercellular adhesion molecule 1 |
TCMBANKGE004562 | CP | CP-2 | ceruloplasmin |
TCMBANKGE000222 | EDN1 | ARCND3; ET1; HDLCQ7; PPET1; QME | endothelin 1 |
TCMBANKGE009992 | ABCC8 | ABC36; HHF1; HI; HRINS; MRP8; PHHI; PNDM3; SUR; SUR1; SUR1delta2; TNDM2 | ATP binding cassette subfamily C member 8 |
TCMBANKGE000935 | S100B | NEF; S100; S100-B; S100beta | S100 calcium binding protein B |
TCMBANKGE000934 | GFAP | ALXDRD | glial fibrillary acidic protein |
TCMBANKGE002521 | CACNA1A | APCA; BI; CACNL1A4; CAV2.1; EA2; EIEE42; FHM; HPCA; MHP; MHP1; SCA6 | calcium voltage-gated channel subunit alpha1 A |
TCMBANKGE000879 | SERPINE2 | GDN; GDNPF; PI-7; PI7; PN-1; PN1; PNI | serpin family E member 2 |
TCMBANKGE000330 | HMOX1 | HMOX1D; HO-1; HSP32; bK286B10 | heme oxygenase 1 |
TCMBANKGE013473 | F2R | CF2R; HTR; PAR-1; PAR1; TR | coagulation factor II thrombin receptor |
TCMBANKGE006961 | F2 | PT; RPRGL2; THPH1 | coagulation factor II, thrombin |
TCMBANKGE012951 | MYLK | AAT7; KRP; MLCK; MLCK1; MLCK108; MLCK210; MMIHS; MSTP083; MYLK1; smMLCK | myosin light chain kinase |